Congenital Hyperinsulinism Treatments
Find Congenital Hyperinsulinism Treatments
Medications for Congenital Hyperinsulinism
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Congenital Hyperinsulinism.
Found 1 Approved Drug for Congenital Hyperinsulinism
Diazoxide
Brand Names
Proglycem, VYKAT
Diazoxide
Brand Names
Proglycem, VYKAT
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: September 30, 1990
PROGLYCEM (ORAL DIAZOXIDE) is useful in the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy. Infants and Children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. PROGLYCEM may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists. PROGLYCEM should be used only after a diagnosis of hypoglycemia due to one of the above conditions has been definitely established. When other specific medical therapy or surgical management either has been unsuccessful or is not feasible, treatment with PROGLYCEM should be considered.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances